AETNA CLINICAL POLICY BULLETIN
Number: 0847
Subject: Inpatient Admission Criteria - Electrolyte Disorders

EFFECTIVE DATE: January 1, 2026

POLICY:
Aetna considers inpatient admission for electrolyte disorders medically necessary 
when clinical documentation supports the need for continuous monitoring and/or 
interventions that cannot be safely provided in an outpatient setting.

HYPERKALEMIA (ICD-11: 5A40):

Inpatient admission is considered medically necessary when ANY of the following 
are documented:

A. SEVERE HYPERKALEMIA:
   - Serum potassium ≥ 6.0 mmol/L, OR
   - Serum potassium ≥ 5.5 mmol/L with ANY EKG abnormality

B. MODERATE HYPERKALEMIA WITH COMPLICATIONS:
   - Serum potassium 5.0-5.9 mmol/L WITH:
     * EKG changes (peaked T waves, prolonged PR, widened QRS)
     * Acute kidney injury (>50% rise in creatinine)
     * Hemodynamic instability
     * Failure of emergency department management

C. RAPID CORRECTION REQUIRED:
   - Need for IV calcium for cardiac stabilization
   - Need for insulin/glucose infusion
   - Need for emergent hemodialysis

DOCUMENTATION REQUIREMENTS:
1. Timed serum potassium levels (minimum 2 values)
2. 12-lead EKG with interpretation
3. Renal function tests
4. Clinical notes documenting symptoms
5. Treatment administered and response

APPEAL PROCESS:
Peer-to-peer review available within 24 hours.
Standard appeals must be filed within 30 days.
Contact: 1-800-AETNA-MD